Hormone & Growth Signaling
Peptides in this category interact with endocrine signaling systems that regulate growth, repair, metabolism, and tissue adaptation. Many function by influencing growth hormone pathways, insulin-like growth factors, or upstream hypothalamic signaling that coordinates systemic anabolic and recovery responses. These compounds are typically discussed in contexts involving recovery capacity, tissue regeneration signaling, metabolic regulation, and adaptive physiological responses to stress, training, and energy balance.
CJC-1295 DAC
Early human dataCJC-1295 DAC is a long-acting GHRH analog research topic with human GH/IGF-1 pharmacology and clear safety limits.
human 2 · sources 5
CJC-1295 no DAC
Early human dataCJC-1295 no DAC is a modified GHRH(1-29) discussion topic centered on GH-axis signaling, pulse-oriented research, and DAC distinction.
human 2 · sources 5
IGF-1 LR3
Early human dataAn engineered growth factor sold as a research chemical. No human trials exist. It's banned in all sport at all times, and the FDA-approved version of the same molecule carries a cancer contraindication.
human 2 · sources 7
Ipamorelin
Early human dataIpamorelin is a ghrelin-receptor growth hormone secretagogue discussed around GH-release research, endocrine selectivity, and safety limits.
human 2 · sources 5
MK-677
Controlled human trialsAn orally active non-peptide that mimics ghrelin and reliably raises growth hormone and IGF-1. Three randomised placebo-controlled trials measured that rise and could not show it changed strength or physical function.
human 4 · sources 7
Sermorelin
Controlled human trialsSermorelin is a GHRH(1-29) analog that was an approved medicine until 2009, with a real randomised trial record in children and almost none in the adults it is now sold to.
human 12 · sources 18